Showing results (21-30 of 142) with videos related to
Sort By:
Pageof 15
Journal of Hematology & Oncology|April 14, 2016
How do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation?Ying-Jun Chang, Leo Luznik, Ephraim J Fuchs, et al.Expert Opinion on Biological Therapy|September 1, 2004
HIV-1 vaccines and co-infectionTara M Robinson, Jean D BoyerAdvances in Therapy|September 23, 2025
Estimated Long-Term Durability of Valoctocogene Roxaparvovec Treatment in Male patients with Severe Hemophilia A: An Extrapolation of Clinical DataSandra Santos, Tara M Robinson, David TruemanInternational Journal of Hematologic Oncology|October 11, 2018
Potential role for all-trans retinoic acid in nonpromyelocytic acute myeloid leukemiaHayley S Ma, Tara M Robinson, Donald SmallDNA and Cell Biology|August 9, 2003
Parasitic infection and the polarized Th2 immune response can alter a vaccine-induced immune responseTara M Robinson, Robin G Nelson, Jean D BoyerBiology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 28, 2014
Mismatched related and unrelated donors for allogeneic hematopoietic cell transplantation for adults with hematologic malignanciesMary Eapen, Paul O'Donnell, Claudio G Brunstein, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2006
Host-derived Langerhans cells persist after MHC-matched allografting independent of donor T cells and critically influence the alloresponses mediated by donor lymphocyte infusionsNadira Durakovic, Karl B Bezak, Mario Skarica, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 8, 2009
Improved survival with inhibitory killer immunoglobulin receptor (KIR) gene mismatches and KIR haplotype B donors after nonmyeloablative, HLA-haploidentical bone marrow transplantationHeather J Symons, M Sue Leffell, Nancy D Rossiter, et al.Journal of Comparative Effectiveness Research|March 21, 2014
Design of a cost-effectiveness analysis alongside a randomized trial of transplantation using umbilical cord blood versus HLA-haploidentical related bone marrow in advanced hematologic cancerJoshua A Roth, Mark E Bensink, Paul V O'Donnell, et al.Blood|January 18, 2007
Factors governing the activation of adoptively transferred donor T cells infused after allogeneic bone marrow transplantation in the mouseNadira Durakovic, Vedran Radojcic, Mario Skarica, et al.Pageof 15